Σάββατο 26 Μαρτίου 2011

Stelios - προτεινόμενες μετοχές ΗΠΑ για αγορά (επένδυση).

Ακολουθούν τα γραφήματα για κάθε μία προτεινόμενη μετοχή και αφορούν
1.- την τελευταία  10 ετία
2.- την  τελευταία  3 ετία

Majesco Entertainment Company (COOL) is a provider of video game products primarily for the family oriented, mass-market consumer. The Company sells its products primarily to large retail chains, specialty retail stores, video game rental outlets and distributors. The Company publishes video games for interactive entertainment hardware platforms, including Nintendo’s DS, DSi and Wii, Sony’s PlayStation 3, or PS3, and PlayStation Portable (PSP), Microsoft’s Xbox 360 and the personal computer (PC). The Company also publishes games for numerous digital platforms, including mobile platforms, such as iPhone, iPad and iPod Touch, as well as online platforms.







Astea International Inc. (ATEA) develops, markets and supports service management software solutions, which are licensed to companies that sell and service equipment, and/or sell and deliver professional services. Astea solutions are used in industries, such as information technology, medical devices and diagnostic systems, industrial controls and instrumentation, retail systems, office automation, imaging systems, facilities management, telecommunications and other industries with equipment sales and service requirements. Astea provides customers with a range of professional consulting, training and customer support services to implement its products and integrate them with other corporate systems, such as back-office financial and enterprise resource planning (ERP) applications.









Achillion Pharmaceuticals, Inc. (ACHN) is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. Within the anti-infective market, the Company focuses on the development of antivirals for the treatment of chronic hepatitis C and the development of antibacterials for the treatment of resistant bacterial infections. As of December 31, 2009, Achillion focused on developing three Hepatitis C virus (HCV) drug candidates: ACH-1625, a protease inhibitor for the treatment of chronic hepatitis C in phase Ib clinical testing; ACH-1095, a NS4A antagonist also for the treatment of chronic hepatitis C, in late stage preclinical testing, and ACH-2684, a high-potency protease inhibitor in preclinical testing. In addition, it has established other product candidates, which include ACH-702 for the treatment of serious bacterial infections and elvucitabine for the treatment of human immunodeficiency virus (HIV) infection.













Silicon Graphics International Corp., (SGI),   formerly Rackable Systems Inc., is a provider of clustered computing and storage, high-performance compute and storage, and data center technologies integrated with a choice of software, customer support services and professional services. It develops, markets and sells a range of low cost, mid-range and high-end computing servers and data storage, as well as differentiating software. It sells data center infrastructure products purpose-built for large-scale data center deployments. The Company groups its products into six categories: Scale Up Servers, Scale Out Servers, Workgroup Servers, Data Storage Systems, Software and Data Center Infrastructure. On May 8, 2009, the Company completed the acquisition of all of the assets of Silicon Graphics, Inc. On February 23, 2010, the Company completed the acquisition of substantially all the assets of Copan Systems, Inc..










SandRidge Energy, Inc (SD)      is a natural gas and oil company. The Company is engaged in the exploration, development and production activities related to the exploitation of its holdings in West Texas. Its areas of focus are the West Texas Overthrust (the WTO) and the Permian Basin. The WTO is a natural gas-prone geological region in Pecos County and Terrell County, Texas and has 562,626 net acres under lease. The WTO includes the Pinon gas field. In the Permian Basin, SandRidge controls approximately 138,691 net acres in West Texas and New Mexico, including approximately 90,000 net acres acquired in December 2009. In December 2009, the Company purchased natural gas and oil properties located in the Permian Basin from Forest Oil Corporation (Forest) and one of its subsidiaries. The Company operates in three segments: exploration and production, drilling and oil field services, and midstream gas services..







Georgia Gulf Corporation (GGC)      is a manufacturer and international marketer of two integrated chemical product lines, chlorovinyls and aromatics. The Company’s primary chlorovinyls products are chlorine, caustic soda, vinyl chloride monomer (VCM), vinyl resins and vinyl compounds, and its aromatics products are cumene, phenol and acetone. The Company operates through four segments: chlorovinyls; window and door profiles and mouldings products; outdoor building products and aromatics. The chlorovinyls segment is a integrated chain of products, which includes chlorine, caustic soda, ethylene dichloride (EDC), VCM and vinyl resins and compounds. The Company’s vinyl-based building and home improvement products are primarily marketed under the Royal Group brand names, and are managed within two segments, window and door profiles and mouldings. In February 2011, the Company acquired Exterior Portfolio.






DUSA Pharmaceuticals, Inc. (DUSA)     is a vertically integrated dermatology company that is developing and marketing Levulan photodynamic therapy (Levulan PDT), and other products for common skin conditions. Its marketed products include Levulan Kerastick 20% Topical Solution with PDT, the BLU-U brand light source, and ClindaReach. The Levulan Kerastick 20% Topical Solution with PDT and the BLU-U were launched for the treatment of non-hyperkeratotic actinic keratoses (AKs), of the face or scalp under former dermatology collaboration. AKs are precancerous skin lesions caused by chronic sun exposure that can develop over time into a form of skin cancer called squamous cell carcinoma.